As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Motion Sickness Drugs Market: By Product: Anticholinergics, Antihistamines; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Motion Sickness Drugs Market Outlook

The global motion sickness drugs market is projected to grow at a CAGR of 4.2% over the forecast period of 2021-2026.

 

Global Motion Sickness Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global motion sickness drugs market is being driven by the growing use of generic drugs as both over the counter (OTC) and prescription drugs. OTC drugs do not require a professional medical prescription, which has made it more accessible and affordable for consumers. OTC drugs give patients the option for self-medication to relieve mild disease-related symptoms. There are a number of antihistamines used as OTC drugs. This will increase the acceptance of antihistamines to stop motion sickness symptoms, which will further improve the demand for motion sickness drugs. Thus, the availability of over-the-counter (OTC) drugs, along with the advent of nauseogenic information technology, are the factors driving the industry further.

 

Properties and Applications

The global motion sickness drugs market can be broadly categorised based on segments like products and regions.

 

Global Motion Sickness Drugs Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Products:
    • Anticholinergics
    • Antihistamines

The EMR report looks into the regional motion sickness drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Motion Sickness Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

A better understanding of neurological mechanisms associated with motion sickness has been provided by techniques such as traditional neurophysiology, pathway mapping, and magnetic resonance imaging (MRI). Nauseogenic IT has emerged as one of the most popular methods of understanding the neurophysiology and brain parts responsible for this disease. Using nauseogenic vehicles allows to examine postural stability of a person and identifies neural or sensory-motor mechanisms that help to achieve positive body stability. Nauseogenic information technology’s critical knowledge will help develop and improve motion sickness drugs, which will aid the industry growth. Hence, the advancement in nauseogenic information technology coupled with the easy availability and accessibility of OTC drugs are the key factors, which are expected to have a positive impact on the industry growth over the forecast period. However, side effects associated with motion sickness drugs can hamper industry growth over the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global motion sickness drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Baxter International Inc. (NYSE: BAX)
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc. 
  • Pfizer Inc. 
  • Prestige Consumer Healthcare Inc. 
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product  Anticholinergics, Antihistamines
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Baxter International Inc., GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Pfizer Inc., Prestige Consumer Healthcare Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

Key Questions Answered in the Market Report

  • How has the global motion sickness drugs market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the market for 2021-2026?
  • What are the major drivers for historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints for historical (2016-2020) and forecast (2021-2026) periods?
  • What are the import and export trends in the global motion sickness drugs market?
  • Who are the top importers and exporters of motion sickness drugs in the industry globally?
  • What is the degree of competition in the global motion sickness drugs market?
  • What are the major events and developments taking place within the industry globally?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Motion Sickness Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Motion Sickness Drugs Historical Market (2016-2020) 
    8.3    Global Motion Sickness Drugs Market Forecast (2021-2026)
    8.4    Global Motion Sickness Drugs Market by Product 
        8.4.1    Anticholinergics
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Antihistamines
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
    8.5    Global Motion Sickness Drugs Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Baxter International Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    GlaxoSmithKline PLC
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Johnson & Johnson Services Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Pfizer Inc. 
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Prestige Consumer Healthcare Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Motion Sickness Drugs Market: Key Industry Highlights, 2016 and 2026
2.    Global Motion Sickness Drugs Historical Market: Breakup by Product (USD Million), 2016-2020
3.    Global Motion Sickness Drugs Market Forecast: Breakup by Product (USD Million), 2021-2026
4.    Global Motion Sickness Drugs Historical Market: Breakup by Region (USD Million), 2016-2020
5.    Global Motion Sickness Drugs Market Forecast: Breakup by Region (USD Million), 2021-2026
6.    North America Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
7.    North America Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
8.    Europe Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
9.    Europe Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
10.    Asia Pacific Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
11.    Asia Pacific Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Latin America Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Latin America Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Middle East and Africa Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Middle East and Africa Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Global Motion Sickness Drugs Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER